Articles by Disease (Lymphoma)

Small Molecule Toxins Targeting Tumor Receptors

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2311-2334
Author(s): Marcin Dyba, Nadya I. Tarasova and Christopher J. Michejda

Cancer-Specific Ligands Identified from Screening of Peptide-Display Libraries

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2335-2343
Author(s): T. Mori

An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2377-2389
Author(s): O.M. Zack Howard and Carole L. Galligan

Relevance of Multidrug Resistance Proteins on the Clinical Efficacy of Cancer Therapy

Journal: Current Drug Delivery
Volume: 1
Page: 203-212
Author(s): V. Merino, N. V. Jiménez-Torres and M. Merino-Sanjuan

G Protein-Coupled Receptor Fusion Proteins in Drug Discovery

Journal: Current Pharmaceutical Design
Volume: 10
Page: 1989-2001
Author(s): G. Milligan, G- J. Feng, R. J. Ward, N. Sartania, D. Ramsay, A. J. McLean and J. J. Carrillo

The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2081-2092
Author(s): A. Picardi, U. Vespasiani Gentilucci, E. M. Zardi, D. D'Avola, A. Amoroso and A. Afeltra

The Immune Responsiveness in Hepatitis C Virus Infected Patients: Effects of Interferon-Alfa / Ribavirin Combined Treatment on the Lymphocyte Response with Special Reference to B Cells

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2093-2100
Author(s): L. Amati, R. Cozzolongo, O. G. Manghisi, R. Cuppone, N. M. Pellegrino, D. Caccavo and E. Jirillo